Breadcrumb Home IMPAACT News IMPAACT News News October 2024 Announcements Call for Self-Nominations: IMPAACT Network Co-Chair October 2024 Announcements IMPAACT Network Chair Key Contributor to Updated WHO Clinical Trial Guidance July 2024 Announcements European Medicines Agency Approves Triumeq PD® for Infants and Young Children Based on IMPAACT Data Search Enter a search term. Filter Topics AllAnnouncementsMeetingsSpotlight SeriesStudy Results Date All202420232022202120202019201820162014 Sort Date AscDate Desc Submit Search Showing 89 news items. March 2021 Announcements Recent Updates to DAIDS Policies, Procedures, and Guidance Documents March 2021 Announcements European Commission Grants EMA Approval for Dolutegravir Dispersible Tablets For the Treatment of Children Living with HIV in Europe March 2021 Announcements IMPAACT 2010 Primary Results Released March 2021 Meetings IMPAACT at CROI 2021 February 2021 Announcements IMPAACT 2032 Funded by the NIH to Evaluate Remdesivir for COVID-19 in Pregnancy February 2021 Meetings IAS 2021 abstract submissions extended to 15 February January 2021 Announcements IMPAACT MOP Updated January 2021 Announcements IMPAACT at R4P 2021 November 2020 Announcements IMPAACT Award November 2020 Announcements IMPAACT 2007 informs U.S. FDA approval of two supplements Pagination Previous page Prev Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Current page 7 Page 8 Page 9 Next page Next
October 2024 Announcements IMPAACT Network Chair Key Contributor to Updated WHO Clinical Trial Guidance
July 2024 Announcements European Medicines Agency Approves Triumeq PD® for Infants and Young Children Based on IMPAACT Data
March 2021 Announcements European Commission Grants EMA Approval for Dolutegravir Dispersible Tablets For the Treatment of Children Living with HIV in Europe
February 2021 Announcements IMPAACT 2032 Funded by the NIH to Evaluate Remdesivir for COVID-19 in Pregnancy
